Mehee Choi, MD, Radiation Oncology, Maywood, IL

MeheeChoiMD

Radiation Oncology Maywood, IL

Assistant Professor, Radiation Oncology, Loyola University Chicago Stritch School of Medici

Dr. Choi is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Choi's full profile

Already have an account?

Education & Training

  • McGaw Medical Center of Northwestern University
    McGaw Medical Center of Northwestern UniversityResidency, Radiation Oncology, 2011 - 2013
  • Oregon Health & Science University
    Oregon Health & Science UniversityResidency, Radiation Oncology, 2009 - 2011
  • Mayo School of Graduate Medical Education
    Mayo School of Graduate Medical EducationInternship, Transitional Year, 2008 - 2009
  • University of Texas Medical School
    University of Texas Medical SchoolClass of 2008

Certifications & Licensure

  • AZ State Medical License
    AZ State Medical License 2019 - 2021
  • IL State Medical License
    IL State Medical License 2011 - 2023
  • OR State Medical License
    OR State Medical License 2010 - Present
  • American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Publications & Presentations

PubMed

Journal Articles

  • A National Cancer Database Analysis of the Effect of Brachytherapy on Overall Survival in Patients with Base of Tongue Cancer  
    Newton J Hurst, Mehee Choi, Scott R Silva, Bahman Emami, Head & Neck

Press Mentions

  • GT Medical Technologies Announces Four Clinical Abstracts at the 2021 ASCO Annual Meeting Related to GammaTile® Therapy for Brain Tumors
    GT Medical Technologies Announces Four Clinical Abstracts at the 2021 ASCO Annual Meeting Related to GammaTile® Therapy for Brain TumorsJune 5th, 2021